Hashimoto disease, also known as chronic lymphocytic thyroiditis, is an autoimmune disorder that affects the thyroid gland. It is one of the most common causes of hypothyroidism in the United States. While the exact cause of Hashimoto disease is unknown, researchers believe that a combination of environmental and genetic factors may be involved. This article will explore the unknowns of Hashimoto disease and discuss the current treatments available for those suffering from the condition.
Hashimoto disease is an autoimmune disorder that affects the thyroid gland. It is caused by the body's immune system mistakenly attacking the thyroid gland and causing inflammation. This inflammation can lead to a decrease in the production of thyroid hormones, resulting in hypothyroidism. Symptoms of Hashimoto disease may include fatigue, weight gain, dry skin, and constipation.
The exact cause of Hashimoto disease is unknown. However, researchers believe that a combination of environmental and genetic factors may be involved. Environmental triggers may include exposure to certain chemicals, toxins, or infections. Genetic factors may include a family history of thyroid disease or a mutation in certain genes.
Hashimoto disease is typically diagnosed through a physical exam and laboratory tests. During the physical exam, the doctor may check for signs of an enlarged thyroid gland, which is often seen in people with Hashimoto disease. Laboratory tests may include a thyroid-stimulating hormone (TSH) test, a free T4 test, and a thyroid peroxidase antibody (TPOAb) test.
The primary treatment for Hashimoto disease is hormone replacement therapy. This involves taking synthetic thyroid hormones to replace the hormones that are not being produced by the thyroid gland. In some cases, doctors may also prescribe medications to help reduce the inflammation in the thyroid gland.
Living with Hashimoto disease can be challenging, but there are steps that can be taken to manage the condition. It is important to follow the treatment plan prescribed by your doctor. This may include taking medications as prescribed and monitoring your thyroid hormone levels regularly. Eating a healthy diet, exercising regularly, and managing stress can also help to manage the symptoms of Hashimoto disease.
Hashimoto disease is an autoimmune disorder that affects the thyroid gland. The exact cause of the disease is unknown, but researchers believe that a combination of environmental and genetic factors may be involved. Diagnosis of Hashimoto disease is typically done through a physical exam and laboratory tests. Treatment of the disease typically involves hormone replacement therapy and medications to reduce inflammation in the thyroid gland. Living with Hashimoto disease can be challenging, but there are steps that can be taken to manage the condition.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation